|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00348 CHINAHEALTHWISE
Nominal 
0.086 +0.003 (+3.614%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 146,317 | 2.998% | 142,058 | 170,079 | 137,853 | 309,969 |
| Cost of Sales | (86,023) | -3.114% | (88,788) | (79,085) | (76,797) | (222,401) |
| Gross Profit | 60,294 | 13.186% | 53,270 | 90,994 | 61,056 | 87,568 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | (216) | (166) | -- | |
| Change in FV & Impairment on Others | (107,790) | 324.270% | (25,406) | (105,629) | (51,553) | (11,486) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (132,059) | 134.143% | (56,401) | (100,580) | (72,929) | (126,327) | |
| Taxation | (2,499) | -- | 2,127 | (2,466) | 3,648 | (547) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | 44,059 | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 2,529 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (134,558) | 147.923% | (54,274) | (103,046) | (25,222) | (124,345) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 8,993 | 23.242% | 7,297 | 6,410 | 18,839 | 18,888 |
| Depreciation & Amortisation | 5,615 | 69.946% | 3,304 | 4,198 | 8,748 | 10,987 |
| Directors' Emoluments | 19,061 | -5.456% | 20,161 | 15,609 | 14,515 | 10,530 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -17.460 | 148.011% | -7.040 | -13.370 | -3.250 | -15.340 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.019 | -- | (0.037) | 0.055 | 0.015 | 0.060 |
| NBV per share ($) | 0.006 | -- | 0.180 | 0.251 | 0.385 | 0.415 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -28,663,000 |
| %Change | -10.040% |
| EPS / (LPS) | HKD -0.037 |
| NBV Per Share ($) | HKD -0.031 |